Who is sponsoring NCT05648877?

NCT05648877 is sponsored by Menoufia University.

What drugs are being tested in NCT05648877?

Interventions in NCT05648877: Ureteroscope.

What condition does NCT05648877 study?

NCT05648877 studies Retrograde Intrarenal Surgery In Management Of Renal Stones.

Is NCT05648877 still recruiting?

NCT05648877 is currently status unknown. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT05648877

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

to Study the Role of Retrograde Intrarenal Surgery in Management of Renal Stones

Status unknown NA Last updated 18 January 2023

What this trial tests

NA trial testing Ureteroscope in Retrograde Intrarenal Surgery In Management Of Renal Stones in 77 participants. Status unknown.

Timeline

1 October 2020

Primary endpoint
25 February 2023

1 April 2023

Quick facts

Lead sponsor	Menoufia University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	77
Start date	1 October 2020
Primary completion	25 February 2023
Estimated completion	1 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

Ureteroscope

Conditions studied

Retrograde Intrarenal Surgery In Management Of Renal Stones — all drugs for Retrograde Intrarenal Surgery In Management Of Renal Stones →

Sponsor

Menoufia University

Who can join

Eligibility, any sex, with Retrograde Intrarenal Surgery In Management Of Renal Stones. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Role Of Retrograde Intrarenal Surgery In Management Of Renal Stones: Single Center Experience

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Menoufia University trials

Trials by the same sponsor.

NCT07522671 — Clinical Performance of 3D-Printed Resin and Zirconia Implant Restorations · NA · recruiting
NCT07516236 — Dynamic SvO2 in Predicting Fluid Responsiveness in Septic Shock · not yet recruiting
NCT07485517 — Deep Versus Moderate Neuromuscular Blocking · NA · recruiting
NCT07506044 — Dexmedetomidine as an Adjuvant During Dural Puncture Epidural · NA · recruiting
NCT07322471 — Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05648877 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Menoufia University
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05648877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing